Hsieh Ming-Ju, Yeh Chao-Bin, Chiou Hui-Ling, Hsieh Ming-Chang, Yang Shun-Fa
* Cancer Research Center, Changhua Christian Hospital, Changhua 50006, Taiwan.
† School of Optometry, Chung Shan Medical University, Taichung 40201, Taiwan.
Am J Chin Med. 2016;44(1):177-95. doi: 10.1142/S0192415X16500129.
High mortality and morbidity rates for hepatocellular carcinoma (HCC) in Taiwan primarily result from uncontrolled tumor metastasis. In our previous studies, we have reported that Dioscorea nipponica Makino extract (DNE) has anti-metastasis effects on human oral cancer cells. However, the effect of DNE on hepatoma metastasis have not been thoroughly investigated and remains poorly understood. To determine the effects of DNE on the migration and invasion in HCC cells we used a wound healing model, Boyden chamber assays, gelatin/casein zymography and Western blotting. Transcriptional levels of matrix metalloproteinase-9 (MMP-9) and urokinase-type plasminogen activator (u-PA) were detected by real-time PCR and promoter assays. In this study, DNE treatment significantly inhibited the migration/invasion capacities of Huh7 cell lines. The results of gelatin/casein zymography and Western blotting revealed that the activities and protein levels of the MMP-9 and u-PA were inhibited by DNE. Tests of the mRNA levels, real-time PCR, and promoter assays evaluated the inhibitory effects of DNE on u-PA expression in human hepatoma cells. A chromatin immunoprecipitation (ChIP) assay showed not only that DNE inhibits u-PA expression, but also the inhibitory effects were associated with the down-regulation of the transcription factors of NF-[Formula: see text]B and SP-1 signaling pathways. Western blot analysis also showed that DNE inhibits PI3K and phosphorylation of Akt. In conclusion, these results show that u-PA expression may be a potent therapeutic target in the DNE-mediated suppression of HCC invasion/migration. DNE may have potential use as a chemo-preventive agent against liver cancer metastasis.
台湾肝细胞癌(HCC)的高死亡率和高发病率主要是由肿瘤转移失控所致。在我们之前的研究中,我们报道了穿山龙提取物(DNE)对人类口腔癌细胞具有抗转移作用。然而,DNE对肝癌转移的影响尚未得到充分研究,人们对此仍知之甚少。为了确定DNE对HCC细胞迁移和侵袭的影响,我们使用了伤口愈合模型、博伊登小室试验、明胶/酪蛋白酶谱分析和蛋白质印迹法。通过实时聚合酶链反应(PCR)和启动子分析检测基质金属蛋白酶-9(MMP-9)和尿激酶型纤溶酶原激活剂(u-PA)的转录水平。在本研究中,DNE处理显著抑制了Huh7细胞系的迁移/侵袭能力。明胶/酪蛋白酶谱分析和蛋白质印迹法的结果显示,MMP-9和u-PA的活性及蛋白水平受到DNE的抑制。对mRNA水平、实时PCR和启动子分析的测试评估了DNE对人肝癌细胞中u-PA表达的抑制作用。染色质免疫沉淀(ChIP)分析表明,DNE不仅抑制u-PA表达,而且这种抑制作用与核因子-κB(NF-κB)和特异性蛋白-1(SP-1)信号通路转录因子的下调有关。蛋白质印迹分析还表明,DNE抑制磷脂酰肌醇-3激酶(PI3K)和蛋白激酶B(Akt)的磷酸化。总之,这些结果表明,u-PA表达可能是DNE介导的抑制HCC侵袭/迁移的有效治疗靶点。DNE可能具有作为抗肝癌转移化学预防剂的潜在用途。